Willy Barton / shutterstock.com
27 April 2021GenericsAlex Baldwin
UK High Court upholds Alcon glaucoma patent
The UK High Court has refused to invalidate an Alcon glaucoma treatment patent in a judgment handed down on Friday, April 23.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Europe
14 April 2014 The UK High Court has invalidated two patents covering Roche’s breast cancer drug Herceptin (trastuzumab) after a challenge by generic drug maker Hospira.
Big Pharma
23 July 2019 The English High Court has ruled that a patent owned by Roche should be revoked on grounds of insufficiency.
Editor's picks
Editor's picks
Europe
14 April 2014 The UK High Court has invalidated two patents covering Roche’s breast cancer drug Herceptin (trastuzumab) after a challenge by generic drug maker Hospira.
Big Pharma
23 July 2019 The English High Court has ruled that a patent owned by Roche should be revoked on grounds of insufficiency.
Europe
14 April 2014 The UK High Court has invalidated two patents covering Roche’s breast cancer drug Herceptin (trastuzumab) after a challenge by generic drug maker Hospira.
Big Pharma
23 July 2019 The English High Court has ruled that a patent owned by Roche should be revoked on grounds of insufficiency.